Skip to main content
Log in

Determination of β-endorphin and substance P in small volumes of human cerebrospinal fluid

  • Original Papers
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

A reversed-phase high-performance liquid chromatography procedure combined with radioimmunoassay (rp-HPLC-RIA) is presented. It makes possible the quantitative determination of the neuropeptides,β-endorphin and substance P, in small volumes of cerebrospinal fluid (CSF). The concentration-dependence of the recovery of the method is demonstrated and the effect of free silanol groups of the stationary phase on the recovery is discussed. CSF was shown to contain 9.6±1.1fmolβ h-endorphin and 12.0±0.9 fmol substance P per ml.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Emrich HM, Nassett L, Gramsch C, John S (1983) Heroin addiction: betaendorphin immunoreactivity in plasma increases during withdrawal. Pharmakopsychiatry 16: 93–96

    Google Scholar 

  • Emson PC, Arregui A, Clement-Jones V, Sandberg BEB, Rossor M (1980) Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntingtons disease. Brain Res 199: 147–180

    Google Scholar 

  • Guillemin R, Ling N, Vargo T (1977) Radioimmunoassays forα-endorphin andβ-endorphin. Biochem Biophys Res Commun 77: 361–366

    Google Scholar 

  • Hermann K, Lang RE, Unger T, Bayer C, Ganten D (1984) Combined HPLC-RIA for the characterization and quantitation measurement of neuropeptides. J Chromatogr 312: 273–284

    Google Scholar 

  • Hosobuchi Y, Emson PC, Iversen LL (1982) Elevated cerebrospinal fluid substance P in arachnoiditis is reduced by systemic administration of morphine. In: Costa E, Trabucchi M (eds) Regulatory peptides: from molecular biology to function. Raven Press, New York, pp 497–500

    Google Scholar 

  • Hunter WM, Greenwood FC (1962) Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194: 495–496

    Google Scholar 

  • Javoy-Agid F, Ruberg M, Pique L, Bertagna X, Taquet H, Studler JM, Cesselin F, Epelbaum J, Agid Y (1984) Biochemistry of the hypothalamus in Parkinsons disease. Neurology 34: 672–675

    Google Scholar 

  • Jolkkonen JT, Soininen HS, Riekkinen PJ (1984)β-endorphin-like-immunoreactivity in cerebrospinal fluid of patients with alzheimer disease. Acta Neurol Scand 69: 234–235

    Google Scholar 

  • Laatikainen TJ, Salminen KR, Sulkava RO, Leppäluoto JP (1985) Determination ofβ-endorphin andβ-lipotropin in human cerebrospinal fluid. Clin Chim Acta 145: 325–329

    Google Scholar 

  • Lewis RV, Stein S, Udenfriend S (1979) Separation of opioid peptides utilizing high-performance liquid chromatography. Int J Peptide Prot Res 13: 493–497

    Google Scholar 

  • Loeber JG, Verhoff J, Burbach JPH, Witter A (1979) Combination of highperformance liquid chromatography and radioimmunoassay is a powerful tool for the specific and quantitative determination of endorphins and related peptides. Biochem Biophys Res Commun 86: 1288–1295

    Google Scholar 

  • Loeber JG, Verhoff J (1981) HPLC and RIA for the specific and quantitative determination of endorphins and related peptides. Meth Enzymol 73: 261–268

    Google Scholar 

  • McDermott JR, Smith AJ, Biggins JA, Chyad Al-Noaemi M, Edwardson JA (1981) Characterization and determination of neuropeptides by HPLC and RIA. J Chromatogr 222: 371–379

    Google Scholar 

  • Morris HR, Etienne AT, Dell A, Albuquerke R (1980) A rapid and specific method for the high resolution purification and characterization of neuropeptides. J Neurochem 34: 574–582

    Google Scholar 

  • Nakao K, Nakai Y, Matsubara S, Konishi T, Nishitana H, Imura H (1980) Immunoreactiveβ-endorphin in human cerebrospinal fluid. J Clin Endocrinol Metab 50: 230–233

    Google Scholar 

  • Nutt JG (1983) Substance P in human cerebrospinal fluid. In: Wood JH (ed) Neurobiology of CSF II. Plenum, New York, pp 67–75

    Google Scholar 

  • Pezzoli G, Panerai AE, Di Giulio A, Longo A, Passerini D, Carenzi A (1984) Methionine-enkephalin, substance P, and homovanillic acid in the CSF of parkinsonian patients. Neurology 34: 516–519

    Google Scholar 

  • Rachlin JR, Fessler RG, Duda EE, Brown FD, Fang V, Mullan S (1984)β- endorphin-like-immunoreactivity increases in human cerebrospinal fluid following routine metrizamid myelography. J Neurosurg 60: 800–802

    Google Scholar 

  • Savoldi F, Mazzella GL, Facchinetti F, Nappi G, Petraglia F, Sinforiani E, Parrini D, Genazzani AR (1983)β-endorphin,β-lipotropin and adrenocorticotropic hormone levels in cerebrospinal fluid, and brain damage in chronic alcoholics. Eur Neurol 22: 265–271

    Google Scholar 

  • Smyth DG (1984) Chromatography of peptides related toβ-endorphin. Anal Biochem 136: 127–135

    Google Scholar 

  • Tenovuo O, Rinne UK, Viljanen MK (1984) Substance P immunoreactivity in the post mortem Parkinsonian brain. Brain Res 303: 113–116

    Google Scholar 

  • Wardlaw SL, Schlachter LB, Tindall GT, Frantz AG (1982)β-endorphin in cerebrospinal fluid after total hypophysectomy. Clin Res 30: 278 A

    Google Scholar 

  • Wiedemann K, Teschemacher H (1983)β-endorphin immunoreactive materials in human plasma determined by a multiple radioimmunoassay system. Life Sci 33 [suppl] 1: 89–92

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henning, K., Wallasch, T.M. & Przuntek, H. Determination of β-endorphin and substance P in small volumes of human cerebrospinal fluid. J. Neural Transmission 67, 105–112 (1986). https://doi.org/10.1007/BF01243363

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01243363

Key words

Navigation